Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-036517

Director bought 5,000 shares at an average $58.04 ($290,212)

From the SEC's structured data for this filing

Trades in this filing

WHITFIELD ROY A · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-05 Purchase : show line 1 in the form +1,600 $55.22 $88,352 173,600 D
2018-06-06 Purchase : show line 2 in the form +2,000 $59.07 $118,140 175,600 D
2018-06-06 Purchase : show line 3 in the form +1,400 $59.80 $83,720 177,000 D
Open-market purchases · 5,000 sh · avg $58.04 · $290,212
Loading xslF345X03/doc4.xml…